ArticleNPJ vaccines2024

A phase III randomized-controlled study of safety and immunogenicity of DTwP-HepB-IPV-Hib vaccine (HEXASIIL

Hitt Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.